This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The shift to virtual alone has already had a profound impact on all conference stakeholders: medical societies themselves, doctors, patients, commercial partners, and professional conference organisers (PCOs). Doctors want a choice. These order of magnitude increases were also reflected at national levels. yes; and 15.7%
Why Pharma Needs Email Marketing Direct Access to HCPs : Doctors, pharmacists, and researchers check their emails frequently for industry updates and medical advancements. Patient Education & Support : Email allows pharmacompanies to provide disease awareness, medication adherence tips, and product updates.
It would be easier for patients, who wouldn’t have to juggle fistfuls of daily medications, and for doctors who’d only have to write one prescription. It may require either health insurance companies or governments or charitable organizations to develop polypills.”
So, how can pharmacompanies use content marketing to engage HCPs and patients effectively ? Pharma brands can develop: Whitepapers on clinical trials showcasing drug effectiveness. Scientific blogs discussing new advancements in oncology, cardiology, or rare diseases. Lets dive in.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content